4-HO-DiPT is a synthetic psychedelic compound belonging to the tryptamine class, structurally similar to psilocin—the active component in magic mushrooms. Known colloquially as “Iprocin,” this compound is recognized for its fast-acting and short-duration effects, particularly those that influence auditory perception and somatic sensation. While it shares chemical roots with naturally occurring psychedelics, 4-HO-DiPT delivers a unique experience that sets it apart from its counterparts.

• Chemical classification: 4-HO-DiPT is a substituted tryptamine, structurally related to 4-AcO-DiPT and psilocin. It features a hydroxy group on the indole ring, contributing to its potent receptor affinity.

• Distinct profile: Unlike most psychedelics that emphasize visual hallucinations, 4-HO-DiPT is often described as primarily auditory, producing unusual distortions in sound and speech.

• Research background: First synthesized by Alexander Shulgin and documented in TiHKAL, 4-HO-DiPT has become a subject of niche research and anecdotal interest among psychonauts.

• Short duration: Effects typically last 2–4 hours, making it ideal for controlled, time-sensitive studies.

• No approved therapeutic use: Although it shows psychoactive potential, 4-HO-DiPT has not been approved for any medical or therapeutic purpose by regulatory authorities.

• Gray-area legality: It remains unscheduled in many regions but could fall under analogue laws in countries like the United States.

• Routes of administration: It is most commonly consumed orally in powder or capsule form, though sublingual methods are occasionally reported in user literature.

Although 4-HO-DiPT and psilocybin both belong to the tryptamine family and share some molecular similarities, they vary significantly in onset, duration, effects, and cultural context. 4-HO-DiPT is synthetic, faster-acting, and often more intense on the body, whereas psilocybin is natural, spiritual, and gentler in many users’ reports.

• Source origin: Psilocybin is naturally found in over 180 species of mushrooms, while 4-HO-DiPT is entirely lab-synthesized.

• Onset and duration: 4-HO-DiPT kicks in within 20–30 minutes and lasts about 2–4 hours, while psilocybin typically requires 30–60 minutes for onset and lasts 4–6 hours.

• Sensory emphasis: 4-HO-DiPT emphasizes auditory distortions, while psilocybin is more visual, mystical, and introspective.

• Physical effects: Users often report a pronounced body load and muscle tension with 4-HO-DiPT, which is less common with psilocybin.

• Mental clarity: Psilocybin generally induces clearer cognitive and emotional insight, while 4-HO-DiPT may produce more chaotic or rapidly shifting mental states.

• Spirituality: Psilocybin is deeply tied to shamanic and ceremonial traditions; 4-HO-DiPT has a more clinical, analytical appeal to researchers and experimental users.

• Legal status: Psilocybin is a Schedule I substance in most countries, while 4-HO-DiPT often resides in an unscheduled but ambiguous legal position.

4-HO-DiPT is considered a research chemical and remains unscheduled in many jurisdictions. However, its legal status is complex due to analogue laws and interpretations that vary from one region to another. It is essential to understand your local regulations before making a purchase.

• United States: 4-HO-DiPT is not specifically scheduled under federal law but may be prosecutable under the Federal Analog Act if intended for human consumption.

• Canada: As of now, 4-HO-DiPT is not listed under the Controlled Drugs and Substances Act. However, legal interpretation may vary.

• European Union: Varies by country—some allow possession for research, while others apply broad analogue rules that could include 4-HO-DiPT.

• Australia and New Zealand: Generally prohibited under blanket psychoactive substance bans.

• Asia and South America: Laws vary greatly and are often subject to strict drug enforcement. We do not recommend ordering to these regions without confirmation of legality.

• Psycho Plug policy: We proactively restrict shipping to countries where 4-HO-DiPT is known to be banned. Orders placed to restricted zones are automatically canceled and refunded.

• Buyer’s responsibility: It is the customer’s legal obligation to research and comply with local laws before placing an order.

4-HO-DiPT produces a variety of psychoactive effects, many of which are unique within the tryptamine class. The compound is especially noted for its profound influence on auditory perception, including distortions in pitch, rhythm, echo, and tonal clarity. Its rapid onset and relatively short duration make it a favorite for researchers exploring time-limited altered states.

• Auditory distortions: Sounds may become layered, echoic, or spatially distorted. Music can seem emotionally amplified or rhythmically disjointed.

• Altered time perception: Users often report a compression or expansion of perceived time during the peak phase.

• Mild visuals: Compared to other psychedelics, visual hallucinations are less dominant, often limited to color enhancement or surface shimmering.

• Physical sensations: Body load can be significant—muscle tension, shivering, and tingling sensations are commonly reported.

• Mood elevation: The compound tends to produce euphoria or laughter, often accompanied by spontaneous emotional shifts.

• Cognitive acceleration: Thought loops, rapid speech, or mental overstimulation may occur at higher doses.

• Aftereffects: Users frequently experience a calm, reflective afterglow that lasts several hours post-peak.

Dosage for 4-HO-DiPT varies depending on intended use, individual sensitivity, and method of ingestion. Due to its potency and rapid onset, accurate measurement using a precision milligram scale is essential for safety and consistency.

• Microdose: 1–3 mg orally; often used for mood enhancement or sensory sharpening without full psychoactive effects.

• Threshold dose: 4–6 mg; minimal perceptual changes begin to surface, including subtle auditory shifts.

• Light dose: 7–10 mg; clear effects appear, including mood changes, sound distortion, and mild physical sensations.

• Common dose: 10–15 mg; a full psychedelic experience with pronounced auditory changes, mild visuals, and altered cognition.

• Strong dose: 16–20 mg+; can produce intense body load, emotional surges, and overwhelming sensory input.

• Titration advice: New users are advised to begin with no more than 6–8 mg to assess sensitivity before scaling.

• Capsule vs. raw powder: When available in capsule form, verify weight and dosage with a scale. Raw powder must be measured carefully with milligram accuracy.

The effects of 4-HO-DiPT are known for their relatively short duration compared to other psychedelics in the tryptamine class. This makes it ideal for research sessions or intentional experiences that do not require extended recovery time. While individual duration may vary depending on dose, metabolism, and setting, the compound follows a fairly consistent timeline.

• Onset: Effects typically begin 20–30 minutes after oral ingestion. Sublingual use may slightly accelerate this window.

• Come-up: The peak develops rapidly, often within 30–45 minutes of onset, making it one of the fastest-acting oral psychedelics.

• Peak effects: Most intense sensations, especially auditory distortions and body load, occur between 45–90 minutes post-dose.

• Duration: Total psychoactive experience ranges from 2 to 4 hours, with most users reporting a noticeable taper after 3 hours.

• Afterglow: A light lingering sense of clarity, relaxation, or residual euphoria may persist for 1–2 hours post-trip.

• Return to baseline: Full return to normal perception is generally achieved within 5 hours, making it suitable for same-day functional recovery.

• Influencing factors: Duration can be affected by food intake, concurrent substances, and dosage levels. Higher doses may slightly extend both peak and afterglow phases.

Proper storage is essential to preserve the chemical integrity, potency, and safety of 4-HO-DiPT. As with most organic tryptamines, 4-HO-DiPT is sensitive to heat, light, moisture, and air—all of which can accelerate degradation and lead to loss of effectiveness.

• Temperature control: Store at cool temperatures, ideally below 20°C (68°F). Refrigeration is recommended for long-term storage.

• Avoid light exposure: 4-HO-DiPT is photosensitive. Exposure to sunlight or fluorescent lighting can degrade the compound. Use UV-proof containers or dark glass jars.

• Moisture protection: Keep the product in a sealed, dry environment. Moisture promotes hydrolysis and can compromise stability.

• Use silica gel packs: Place desiccant packs inside the storage container to absorb ambient humidity and extend shelf life.

• Minimize air contact: Exposure to oxygen can accelerate oxidation. Use vacuum-sealed bags or airtight containers to limit air exchange.

• Avoid frequent opening: Opening the container repeatedly introduces light and air. If using small amounts frequently, separate into micro-storage units.

• Storage lifespan: When stored correctly, 4-HO-DiPT can maintain its potency for 18–24 months. Improper storage can reduce this to under 6 months.

While there is no known lethal dose of 4-HO-DiPT and many users report positive experiences, the compound is still classified as a research chemical with limited clinical safety data. Responsible use, proper dosing, and controlled environments are critical for minimizing risk.

• Lack of clinical studies: To date, there are no peer-reviewed, long-term safety studies on 4-HO-DiPT. Most knowledge stems from anecdotal reports and underground research.

• Psychological effects: The compound can induce anxiety, paranoia, or disorientation, especially in high doses or unfamiliar settings.

• Physical risks: Side effects may include nausea, muscle tension, increased heart rate, sweating, or chills. These are usually dose-dependent and temporary.

• Mental health considerations: Those with a history of psychosis, schizophrenia, or severe anxiety disorders should avoid all psychedelics, including 4-HO-DiPT.

• Polydrug interactions: Combining with substances like alcohol, SSRIs, or MAOIs increases the risk of adverse reactions and serotonin syndrome.

• Tolerance and overuse: Frequent use can lead to short-term tolerance. It’s not physically addictive but may encourage psychological dependency in vulnerable users.

• Recommended precautions: Use in a calm, familiar setting with a sober sitter. Always test the product’s potency with a low dose first.

Many experimental users have explored 4-HO-DiPT as a microdosing candidate, primarily for its unique auditory effects and short duration. However, its use in this context is not widely studied, and results vary by individual. Microdosing should always be approached cautiously, especially with lesser-known compounds.

• Typical microdose range: 1–3 mg orally is considered a microdose. Some users report effects at doses as low as 0.5 mg.

• Cognitive impact: Microdoses may promote increased alertness, mental clarity, or sound sensitivity without full psychedelic effects.

• Emotional shifts: Some individuals report improved mood, reduced anxiety, or increased emotional receptivity. Others may experience irritability or overstimulation.

• Sensory enhancement: Auditory perception may subtly shift, enhancing appreciation for music or environmental sounds even at low doses.

• Short window of effect: Effects usually last under 3 hours, allowing users to plan doses around work or creative sessions.

• Safety for microdosing: Always measure precisely with a calibrated milligram scale. Even minor errors can lead to unintended psychoactive effects.

• Tolerance considerations: As with all psychedelics, microdosing too frequently (e.g., daily) may result in diminished returns or sensitivity. A schedule such as one dose every 3 days is commonly used.

4-HO-DiPT is most commonly consumed orally, either as raw powder or encapsulated for more convenient dosing. Alternate methods like sublingual use exist but are less popular due to taste and variability in absorption. Inhalation and injection are not advised due to lack of safety data.

• Oral ingestion: The most common method. Doses are measured with a precision scale and consumed in capsule form or mixed with water.

• Capsule form: Offers easy, accurate dosing and avoids unpleasant taste. Many users pre-load doses into gelatin or vegetarian capsules.

• Sublingual administration: Holding the substance under the tongue may offer faster onset but has a strong bitter flavor and unpredictable absorption.

• Avoid nasal insufflation: Not recommended due to potential irritation, rapid absorption, and risk of overdose.

• Not suitable for vaporizing or smoking: The compound is not thermally stable and may degrade or produce harmful byproducts under heat.

• Precise measurement is essential: Even 1–2 mg over the intended dose can drastically intensify effects. Always use a 0.001g digital scale.

• Avoid mixing with food: Consumption on a light or empty stomach enhances onset and consistency. Heavy meals may delay or blunt effects.

Mixing 4-HO-DiPT with other psychedelics or substances is generally discouraged unless you have a deep understanding of the pharmacology and interactions involved. Combining compounds can produce unpredictable, sometimes dangerous effects, increasing both physical and psychological risks.

• Increased intensity: Combining 4-HO-DiPT with other serotonergic psychedelics like LSD, psilocybin, or 4-AcO-DMT can dramatically amplify auditory and visual distortions, sometimes leading to sensory overload.

• Unpredictable synergy: Different substances may potentiate or cancel each other’s effects unpredictably, which can result in heightened anxiety, paranoia, or confusion.

• Risk of serotonin syndrome: Mixing serotonergic substances, including SSRIs or MAOIs, with 4-HO-DiPT raises the risk of serotonin syndrome, a potentially life-threatening condition.

• Physical strain: Stacking compounds can exacerbate cardiovascular stress, muscle tension, and nausea.

• Mental health risks: Poly-drug use increases the likelihood of acute psychotic episodes or panic attacks, especially in users with pre-existing vulnerabilities.

• Lack of research: There are no formal clinical studies on 4-HO-DiPT combinations, meaning all interaction data is anecdotal and uncertain.

• Harm reduction advice: Avoid mixing unless absolutely necessary, and if doing so, start with low doses, have a trusted sober sitter present, and stay in a safe environment.

Like most tryptamines, 4-HO-DiPT induces rapid short-term tolerance. This means that repeated use over a short period diminishes the compound’s effects and may require increasing doses to achieve similar results.

• Tolerance onset: Tolerance develops quickly—often after a single dose, making subsequent doses within 24–48 hours significantly less effective.

• Cross-tolerance: There is cross-tolerance between 4-HO-DiPT and other serotonergic psychedelics such as psilocybin, LSD, and 4-AcO-DMT. Using any of these substances reduces sensitivity to the others.

• Tolerance duration: Most tolerance dissipates within 3–5 days after last use, but full baseline sensitivity may take longer in heavy users.

• Mechanism: Tolerance is believed to result from downregulation or desensitization of serotonin 5-HT2A receptors, the primary site of psychedelic action.

• Implications for microdosing: Repeated microdosing can also induce tolerance, reducing the compound’s subtle effects over time.

• Avoid redosing: Rapid redosing to chase effects may increase the risk of adverse psychological reactions and physical discomfort.

• Recommended breaks: Users generally take breaks of at least one week between doses to minimize tolerance build-up and preserve effect integrity.

While 4-HO-DiPT is often described as relatively safe within controlled research settings, it carries several risks that users should be fully aware of before use. Responsible use and harm reduction strategies are essential.

• Psychological distress: High doses or unsafe environments can provoke anxiety, panic attacks, paranoia, and confusion.

• Sensory overload: Intense auditory distortions may overwhelm some users, causing discomfort or disorientation.

• Physical side effects: Muscle tension, nausea, headaches, and chills are common, particularly at higher doses.

• Risk of accidents: Impaired judgment and altered perception can lead to risky behavior or accidents.

• Unknown long-term effects: There is no long-term safety data available, so repeated or chronic use may carry unknown risks.

• Potential drug interactions: Combining 4-HO-DiPT with antidepressants, MAOIs, or other medications can cause dangerous reactions.

• Legal repercussions: Possession or distribution may lead to legal penalties in certain jurisdictions.

• Mental health vulnerabilities: Individuals with a history of psychosis or severe mental illness should avoid use entirely.

4-HO-DiPT is a research chemical not typically included in standard drug screening panels. However, detection depends on the type of test and analytical method used.

• Standard drug screens: Typical urine or blood drug tests do not test for 4-HO-DiPT or related tryptamines.

• Specialized testing: Advanced forensic or toxicological labs using mass spectrometry or chromatography may detect 4-HO-DiPT if specifically targeted.

• Detection window: The compound is metabolized relatively quickly, usually clearing detectable levels within 24–48 hours.

• Metabolites: Limited data exists on its metabolites, but some may be detectable longer than the parent compound.

• Implications for users: Unless undergoing specialized testing, it is unlikely to be detected, but no guarantee exists, especially in forensic or employment contexts.

• Legal risk: Positive detection may carry legal consequences depending on jurisdiction.

Transporting 4-HO-DiPT internationally is risky and generally not advised due to legal complexities and customs enforcement.

• Customs scrutiny: Airports and border security have advanced screening tools and may seize packages or personal items containing psychedelics.

• Legal status variations: Even if legal in your departure or arrival country, transit countries may have stricter controls.

• Packaging risks: Despite discreet packaging, possession of powder substances often raises suspicion.

• Legal consequences: Arrest, fines, or imprisonment are possible if caught with controlled substances.

• Shipping vs. personal carriage: Shipping through trusted services with experience in discreet packaging is safer than personal transport.

• Alternative solutions: Consider sourcing locally or ordering from reputable suppliers that ship discreetly.

• Compliance: Always research local laws thoroughly before attempting to travel with any psychoactive substances.